Short answer
ICU MEDICAL INC/DE (ICUI) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $552M (up 0.5% year over year) with net income of −$11M.
Q2 2026 key financials · XBRL
- Revenue
- $552M
- +0.5% YoY · +4.0% QoQ
- Net income
- −$11M
- −121.7% YoY · −136.7% QoQ
- Operating margin
- 7.1%
- Gross margin
- 42.6%
- EPS (diluted)
- $0.76
- −46.9% YoY · −36.7% QoQ
Source: XBRL data from the ICU MEDICAL INC/DE (ICUI) Q2 2026 10-Q on SEC EDGAR. USD.
ICU MEDICAL INC/DE Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability or margin percentages disclosed in supplied text
- $18.9M tariff refunds recognized in cost of goods sold during Q2 2026
- $0.7M related tariff-refund interest income recognized in interest expense, net
- $211.2M IV Solutions transaction proceeds, including $200.0M Term Loan A repayment in Q2 2025
Risk Factors
- No Risk Factors section provided in the excerpt
- No disclosed new or changed risks identifiable from the provided text
- Credit Agreement restrictions limit stock repurchases under the $100 million authorization
- CFO Rule 10b5-1 plan covers 24,535 securities through June 1, 2027
- General Counsel Rule 10b5-1 plan covers 4,856 securities through June 4, 2027
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ICU MEDICAL INC/DE quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.